Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report

Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report

Abstract Background Sodium–glucose cotransporter-2(SGLT-2) inhibitors are a newer class of antidiabetic drugs with the increased risk of euglycemic diabetic ketoacidosis(EuDKA). Encephalopathy is a rare but life-threatening event of EuDKA. Due to paradoxically normal or slightly elevated serum gluco...

Full description

Saved in:
Bibliographic Details
Main Authors: Lulu Chu, Zhenhua Xi, Runzhi Ma, Weiliang Shi, Guoshen Yu
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Neurology
Subjects:
Dapagliflozin
Euglycemic diabetic ketoacidosis
Metabolic encephalopathy
Sodium–glucose cotransporter-2 inhibitors
Case report
Online Access:https://doi.org/10.1186/s12883-025-04027-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items